Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
AIDS Research and Therapy
|
August 12, 2011
Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment
Edward R Cachay, David L Wyles, Miguel Goicoechea, et al.
Health & Justice
|
August 10, 2022
A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation
Kevin F Kamis, David L Wyles, Matthew S Minturn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 2, 2011
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials
Lynn E Taylor, Marisa Holubar, Kunling Wu, et al.
MMWR. Morbidity and Mortality Weekly Report
|
May 9, 2014
Early identification and linkage to care of persons with chronic hepatitis B virus infection--three U.S. sites, 2012-2014
Geoff A Beckett, Gilberto Ramirez, Aaron Vanderhoff, et al.
British Journal of Clinical Pharmacology
|
October 28, 2019
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s
Charles S Venuto, Yoninah S Cramer, Susan L Rosenkranz, et al.
AIDS (London, England)
|
May 30, 2014
High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response
Berta Pernas, Marta Grandal, Alvaro Mena, et al.
The Journal of Infectious Diseases
|
May 15, 2020
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation
Donald D Anthony, Mark S Sulkowski, Laura M Smeaton, et al.
Open Forum Infectious Diseases
|
September 12, 2022
The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population
Nicole D Ferrante, Craig W Newcomb, Kimberly A Forde, et al.
The Journal of Infectious Diseases
|
June 8, 2014
Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response
Jennifer C Lin, François Habersetzer, Maribel Rodriguez-Torres, et al.
Gastroenterology
|
July 27, 2016
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis
Edward Gane, Fred Poordad, Stanley Wang, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
AIDS Research and Therapy
|
August 12, 2011
Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment
Edward R Cachay, David L Wyles, Miguel Goicoechea, et al.
Health & Justice
|
August 10, 2022
A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation
Kevin F Kamis, David L Wyles, Matthew S Minturn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 2, 2011
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials
Lynn E Taylor, Marisa Holubar, Kunling Wu, et al.
MMWR. Morbidity and Mortality Weekly Report
|
May 9, 2014
Early identification and linkage to care of persons with chronic hepatitis B virus infection--three U.S. sites, 2012-2014
Geoff A Beckett, Gilberto Ramirez, Aaron Vanderhoff, et al.
British Journal of Clinical Pharmacology
|
October 28, 2019
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s
Charles S Venuto, Yoninah S Cramer, Susan L Rosenkranz, et al.
AIDS (London, England)
|
May 30, 2014
High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response
Berta Pernas, Marta Grandal, Alvaro Mena, et al.
The Journal of Infectious Diseases
|
May 15, 2020
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation
Donald D Anthony, Mark S Sulkowski, Laura M Smeaton, et al.
Open Forum Infectious Diseases
|
September 12, 2022
The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population
Nicole D Ferrante, Craig W Newcomb, Kimberly A Forde, et al.
The Journal of Infectious Diseases
|
June 8, 2014
Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response
Jennifer C Lin, François Habersetzer, Maribel Rodriguez-Torres, et al.
Gastroenterology
|
July 27, 2016
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis
Edward Gane, Fred Poordad, Stanley Wang, et al.
Page
of 8